Earnings watch · AVNT · Basic Materials

Avient Corp (AVNT) shows negative returns across 1-, 4- and 12-week spans

The Aug. 6 earnings date gives the specialty-polymer materials maker a near-term catalyst after a soft weekly tape.

Avient Corp
Latest36.32 USD
1W move-3.4%
Volume0.8x
TrendInactive
Specialty polymer materials and testing equipment with a market-data terminal in the background.

Market update

What happened

Avient Corp (AVNT) ended the latest week at 36.32 USD ahead of its scheduled Aug. 6 earnings report for the fiscal period ended June 30. The earnings calendar shows an EPS estimate of 0.89 USD.

The weekly price path over 52 weeks gives context rather than intraday direction. The trend signal is inactive, volume sat below its 13-week average, and Market Dynamics showed only slight improvement at 0.03, leaving the setup mixed.

Continue your research

Explore AVNT across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

Specialty Chemicals coverage

Evidence context